[PHARMA] QoQ Quarter Result on 31-Dec-2019 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
QoQ- -37230.56%
YoY- -4125.2%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 624,804 645,763 819,921 715,683 716,849 601,890 786,108 -14.16%
PBT 4,093 14,326 30,880 -238,474 3,885 12,481 30,243 -73.54%
Tax -2,799 -4,719 -8,465 59,741 -3,509 -3,219 -10,595 -58.72%
NP 1,294 9,607 22,415 -178,733 376 9,262 19,648 -83.61%
-
NP to SH 1,442 9,979 22,399 -178,598 481 9,281 19,617 -82.36%
-
Tax Rate 68.39% 32.94% 27.41% - 90.32% 25.79% 35.03% -
Total Cost 623,510 636,156 797,506 894,416 716,473 592,628 766,460 -12.82%
-
Net Worth 345,040 357,891 350,047 336,573 516,387 518,564 528,825 -24.71%
Dividend
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Div 3,920 6,530 15,673 - - 6,514 15,630 -60.13%
Div Payout % 271.91% 65.45% 69.98% - - 70.19% 79.68% -
Equity
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Net Worth 345,040 357,891 350,047 336,573 516,387 518,564 528,825 -24.71%
NOSH 261,705 261,705 261,229 261,229 261,229 261,229 260,505 0.30%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 0.21% 1.49% 2.73% -24.97% 0.05% 1.54% 2.50% -
ROE 0.42% 2.79% 6.40% -53.06% 0.09% 1.79% 3.71% -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 239.03 247.20 313.87 274.30 274.86 230.98 301.76 -14.35%
EPS 0.55 3.82 8.57 -68.45 0.18 3.56 7.53 -82.44%
DPS 1.50 2.50 6.00 0.00 0.00 2.50 6.00 -60.21%
NAPS 1.32 1.37 1.34 1.29 1.98 1.99 2.03 -24.88%
Adjusted Per Share Value based on latest NOSH - 261,229
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 43.35 44.81 56.89 49.66 49.74 41.76 54.54 -14.15%
EPS 0.10 0.69 1.55 -12.39 0.03 0.64 1.36 -82.36%
DPS 0.27 0.45 1.09 0.00 0.00 0.45 1.08 -60.21%
NAPS 0.2394 0.2483 0.2429 0.2335 0.3583 0.3598 0.3669 -24.71%
Price Multiplier on Financial Quarter End Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 -
Price 4.32 2.22 1.26 2.06 2.44 2.84 2.27 -
P/RPS 1.81 0.90 0.40 0.75 0.89 1.23 0.75 79.63%
P/EPS 783.09 58.12 14.69 -3.01 1,322.99 79.74 30.14 772.03%
EY 0.13 1.72 6.81 -33.23 0.08 1.25 3.32 -88.40%
DY 0.35 1.13 4.76 0.00 0.00 0.88 2.64 -73.90%
P/NAPS 3.27 1.62 0.94 1.60 1.23 1.43 1.12 103.87%
Price Multiplier on Announcement Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 19/11/20 19/08/20 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 -
Price 5.72 4.42 1.88 2.04 2.21 2.66 2.36 -
P/RPS 2.39 1.79 0.60 0.74 0.80 1.15 0.78 110.53%
P/EPS 1,036.87 115.71 21.93 -2.98 1,198.28 74.69 31.34 924.03%
EY 0.10 0.86 4.56 -33.55 0.08 1.34 3.19 -89.99%
DY 0.26 0.57 3.19 0.00 0.00 0.94 2.54 -78.02%
P/NAPS 4.33 3.23 1.40 1.58 1.12 1.34 1.16 140.05%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment